Search
Microbot Medical Inc
MBOTAdd to Watchlist
1.910USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
128.28MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
0.00%
5 Days
+7.91%
1 Month
-4.98%
6 Months
-9.48%
Year to Date
-4.50%
1 Year
-23.60%
Key Figures
1.920Open
1.979High
774.48KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
1.18%Turnover Ratio
1.910Prev. Close
1.870Low
1.09MTurnover
LossP/E Static
1.61P/B
0.00%Div Yield TTM
-26.09%ROA
4.67052wk High
1.40Volume Ratio
-11.44MNet Profit
65.83MShares
-0.2580EPS TTM
1.03Beta
-27.58%ROE
1.60052wk Low
5.71%Amplitude
1.90%Gross Margin
128.28MMarket Cap
-0.71Reward/Risk
4.26%Risk Rate
TradingKey Stock Score of Microbot Medical Inc
Currency: USD Updated: 2026-07-02Key Insights
Microbot Medical Inc's fundamentals are relatively healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 134 out of 387 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 7.00.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Microbot Medical Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Microbot Medical Inc Highlights
StrengthsRisks
Microbot Medical Inc. is a pre-commercial stage medical technology company. It has developed the single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. It specializes in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. It eliminates the need for extensive capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. Its addressable markets for the LIBERTY Endovascular Robotic Surgical System include the peripheral interventional radiology, interventional cardiology and interventional neuroradiology markets.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 0.00.
Undervalued
The company’s latest PE is -7.40, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 15.51M shares, increasing 25.62% quarter-over-quarter.
Held by Bill Nygren | OAKMX
Star Investor Bill Nygren | OAKMX holds 352.34 shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.67.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
7.000
Target Price
+274.33%
Upside Space
Microbot Medical Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Microbot Medical Inc Info
Microbot Medical Inc. is a pre-commercial stage medical technology company. It has developed the single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. It specializes in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. It eliminates the need for extensive capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. Its addressable markets for the LIBERTY Endovascular Robotic Surgical System include the peripheral interventional radiology, interventional cardiology and interventional neuroradiology markets.
Ticker SymbolMBOT
CompanyMicrobot Medical Inc
CEOGadot (Harel)
Websitehttp://www.microbotmedical.com/
Related Instruments
+1.62%
+3.50%
+3.96%
+3.72%
+3.31%
+6.14%
+3.55%
+3.40%
+4.21%
+1.80%
+6.03%
+2.95%
+4.62%
+3.68%
+2.35%
0.00%
+4.73%
+3.32%
+0.41%
+4.98%Popular Instruments
53002.700
+160.200 (+0.30%)
29618.200
+306.800 (+1.05%)
7512.800
+41.300 (+0.55%)
15012.000
+209.000 (+1.41%)
69801.000
+1653.000 (+2.43%)
6388.700
+35.900 (+0.56%)
68.863
+0.519 (+0.76%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4172.420
+50.510 (+1.23%)
FAQs
What is the current price of Microbot Medical Inc (MBOT)?
The current price of Microbot Medical Inc (MBOT) is 1.91.
What is the symbol of Microbot Medical Inc?
The ticker symbol of Microbot Medical Inc is MBOT.
What is the 52-week high of Microbot Medical Inc?
The 52-week high of Microbot Medical Inc is 4.67.
What is the 52-week low of Microbot Medical Inc?
The 52-week low of Microbot Medical Inc is 1.60.
What is the market capitalization of Microbot Medical Inc?
The market capitalization of Microbot Medical Inc is 125.74M.
Is Microbot Medical Inc (MBOT) currently rated as Buy, Hold, or Sell?
According to analysts, Microbot Medical Inc (MBOT) has an overall rating of Buy, with a price target of 7.00.
What is the Earnings Per Share (EPS TTM) of Microbot Medical Inc (MBOT)?
The Earnings Per Share (EPS TTM) of Microbot Medical Inc (MBOT) is -0.29.